Despite the existence of a simplified classification, the Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE), this molecular classification is not implemented in all centers due to the technical complexity of analyzing the POLE mutations. The gene discussed is POLE; the disease is endometrial cancer.